前列腺癌患者光子调强放疗稳健性特征描述:作为质子治疗稳健性评估的拟议基准
本研究回顾性分析2019年单中心27例接受前列腺单独根治性X线放疗的前列腺腺癌患者,量化光子调强放疗的稳健性参数。结果显示最差情况摆位误差下CTV覆盖仍良好,但最差情况下危及器官常超出名义计划机构约束。作者提出X线计划的稳健性指标可作为质子治疗稳健优化与评估的基准。
要点
- 27例前列腺癌患者X线计划名义CTV V100%均值99.6%,最差情况摆位误差下均值97.2%。
- 超过95%的计划在最差情况下达到CTV V100%>90%和CTV V95%>99%。
- 最差情况下直肠V70 Gy和膀胱V60 Gy均值较名义计划升高,常超出机构约束。
核心结论
- X线计划利用PTV margins为患者摆位误差提供固有稳健性,前列腺在各摆位不确定场景下覆盖仍良好,但最差情况下危及器官常超出名义治疗计划机构约束。
- 从X线计划获得的稳健性指标可作为质子治疗稳健优化与评估的基准。
研究设计与样本
- 回顾性分析2019年单中心连续接受前列腺单独根治性X线放疗的前列腺腺癌患者。
- 主要队列采用CTV至PTV margins各方向7 mm、后方4 mm,计划归一化至PTV V100%≥95%。
- 通过在各基本方向相对于患者移动等中心模拟摆位误差,移动幅度等于该方向CTV至PTV外扩幅度,距离不确定度设为0%。
主要发现
- 共评估27例患者,名义计划CTV V100%均值(SD)为99.6%(1.1%),最差情况摆位误差下CTV V100%均值(SD)为97.2%(2.8%)。
- 名义和最差情况CTV V95%均值(SD)分别为100%(0%)和99.7%(0.5%)。
- 超过95%的计划达到最差情况CTV V100%>90%和最差情况CTV V95%>99%。
- 名义和最差情况直肠V70 Gy均值(SD)分别为2.37 cc(1.00 cc)和11.60 cc(3.16 cc)。
- 名义和最差情况膀胱V60 Gy均值(SD)分别为7.8%(4.8%)和14.5%(9.3%),配对双侧t检验比较名义与最差情况剂量体积直方图各参数均有统计学意义(P<.01)。
关键数值与推荐
- 主要队列CTV至PTV margins为各方向7 mm、后方4 mm。
- 计划归一化至PTV V100%≥95%。
- 摆位误差模拟幅度等于该方向CTV至PTV外扩幅度,距离不确定度设为0%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Robustness evaluation is increasingly used in particle therapy planning to assess clinical target volume (CTV) coverage in the setting of setup and range uncertainty. However, no clear standard exists as to an acceptable degree of plan robustness. The aim of this study is to quantify x-ray robustness parameters, as this could inform proton planning when held to a similar standard. METHODS AND MATERIALS: Consecutive patients with prostate adenocarcinoma treated with definitive x-irradiation to the prostate alone at a single institution in 2019 were retrospectively reviewed. CTV to planned target volume (PTV) margins of 7 mm in all directions, except 4 mm posteriorly, were used in the main cohort. Plans were normalized to PTV V100% ≥ 95%. Patient setup errors were simulated by shifting the isocenter relative to the patient in each of the cardinal directions. The magnitude of each shift equaled the magnitude of the CTV to PTV expansion in that direction. Range uncertainty was set to 0%. RESULTS: A total of 27 patients were evaluated. The mean (SD) nominal plan CTV V100% was 99.6% (1.1%). The mean (SD) worst-case shift CTV V100% was 97.2% (2.8%). The mean (SD) nominal and worst-case CTV V95% were 100% (0%) and 99.7% (0.5%), respectively. A worst-case CTV V100% > 90% and a worst-case CTV V95% > 99% were achieved in over 95% of plans. The mean (SD) nominal and worst-case rectal V70 Gy were 2.37 cc (1.00 cc) and 11.60 cc (3.16 cc), respectively. The mean (SD) nominal and worst-case bladder V60 Gy were 7.8% (4.8%) and 14.5% (9.3%), respectively. Paired 2-tailed t tests comparing the nominal to worst-case dose-volume histograms were significant for each dosimetric parameter (P < .01). CONCLUSIONS: X-ray planning uses PTV margins to inherently provide robustness to patient setup errors. Although the prostate remains well covered in various setup uncertainty scenarios, organs at risk routinely exceeded nominal treatment plan institutional constraints in the worst-case scenarios. Robustness metrics obtained from x-ray plans could serve as a benchmark for proton therapy robust optimization and evaluation.
引用
- Maas JA, McDonald AM, Cardan RA, et al. Characterization of Photon Intensity Modulated Radiation Therapy Robustness in Patients With Prostate Cancer as a Proposed Benchmark for Proton Therapy Robustness Evaluation. Pract Radiat Oncol. 2023. PMID: 37748679. doi:10.1016/j.prro.2023.09.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。